Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure

Augmentation of glucose metabolism with perhexiline in non-ischaemic heart failure

Bibliografiska uppgifter
Huvudupphovsmän:	Lee, L, Scheurmann-Freestone, M, Campbell, R, Field, R, Gunaruwan, P, Horowitz, J, Clarke, K, Frenneaux, M
Materialtyp:	Conference item
Publicerad:	2004

Liknande verk

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.
av: Lee, L, et al.
Publicerad: (2005)

Perhexiline.
av: Ashrafian, H, et al.
Publicerad: (2007)

Effects of perhexiline on ketone body and triglyceride synthesis in patients with refractory angina or heart failure
av: Shivu, G, et al.
Publicerad: (2008)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
av: Abozguia, K, et al.
Publicerad: (2009)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
av: Abozguia, K, et al.
Publicerad: (2010)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
av: Abozguia, K, et al.
Publicerad: (2010)

Metabolic mechanisms in heart failure.
av: Ashrafian, H, et al.
Publicerad: (2007)

Metabolic modulation in heart failure: the coming of age.
av: Ashrafian, H, et al.
Publicerad: (2007)

Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
av: Cher-Rin Chong, et al.
Publicerad: (2022-09-01)

Is ischaemic heart failure an autoimmune disease?
av: Susanne Sattler
Publicerad: (2024-04-01)

Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy.
av: Gehmlich, K, et al.
Publicerad: (2014)

Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
av: Bimala Dhakal, et al.
Publicerad: (2023-03-01)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
av: Brkić Milena, et al.
Publicerad: (2022-01-01)

Adiponectin as a Biomarker at Different Stages of Ischaemic Heart Disease: From Obesity to Ischaemic Heart Failure
av: Antonopoulos, A, et al.
Publicerad: (2009)

Prognostic impact over time of ischaemic heart disease vs. non‐ischaemic heart disease in heart failure
av: Jonas Silverdal, et al.
Publicerad: (2020-02-01)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
av: Gabriela Reyes-Castellanos, et al.
Publicerad: (2023-06-01)

Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
av: Bimala Dhakal, et al.
Publicerad: (2023-04-01)

Mathematical modelling of the ischaemic heart
av: Mulquiney, P, et al.
Publicerad: (2001)

Mathematical modelling of the ischaemic heart
av: Mulquiney, P, et al.
Publicerad: (2001)

Modification of myocardial substrate use as a therapy for heart failure.
av: Abozguia, K, et al.
Publicerad: (2006)

Patients with obstructive sleep apnoea have impaired cardiac metabolism and diastolic dysfunction compared to controls
av: West, S, et al.
Publicerad: (2005)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
av: Tobias J. Pfeffer, et al.
Publicerad: (2021-08-01)

Ischaemic Heart Disease
av: K R Mahajan
Publicerad: (2013-04-01)

Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
av: Diem H. Tran, et al.
Publicerad: (2019-06-01)

Stem cell therapy for ischaemic heart disease and congestive heart failure
av: Martin-Rendon, E, et al.
Publicerad: (2009)

Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart
av: Sidell, R, et al.
Publicerad: (2001)

Prevalence of heart failure preserved ejection fraction in the community
av: Mahadevan, G, et al.
Publicerad: (2007)

The three‐dimensional speckle tracking echocardiography in distinguishing between ischaemic and non‐ischaemic aetiology of heart failure
av: Marianna Vachalcova, et al.
Publicerad: (2020-10-01)

Pinocembrin ameliorates arrhythmias in rats with chronic ischaemic heart failure
av: Yan Guo, et al.
Publicerad: (2021-01-01)

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
av: Amy Groenewegen, et al.
Publicerad: (2021-06-01)

Treatment response in recent‐onset heart failure with reduced ejection fraction: non‐ischaemic vs. ischaemic aetiology
av: Jonas Silverdal, et al.
Publicerad: (2023-02-01)

Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure.
av: Nightingale, A, et al.
Publicerad: (2007)

Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs.
av: Andreka, G, et al.
Publicerad: (2007)

Pacing in congestive heart failure
av: Frenneaux Michael P, et al.
Publicerad: (2000-10-01)

Abnormal cardiac and skeletal muscle function and energetics correlate with insulin resistance in heart failure
av: Scheuermann-Freestone, M, et al.
Publicerad: (2004)

Predictors of ischaemic heart disease in a Malaysian population with the metabolic syndrome
av: Yeow, T.P., et al.
Publicerad: (2012)

Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure
av: Thomas R. Godec, et al.
Publicerad: (2022-06-01)

Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure
av: McAndrew, DJ, et al.
Publicerad: (2022)

Homoarginine and creatine deficiency do not exacerbate murine ischaemic heart failure
av: Debra J. McAndrew, et al.
Publicerad: (2023-02-01)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
av: Edoardo Gronda, et al.
Publicerad: (2020-12-01)